Synaptic loss has long been suspected in schizophrenia, but identifying modifiable upstream drivers — ones that could be targeted before full illness onset — has proven elusive. This PET imaging study offers a rare in-vivo window into how everyday psychological stress relates to the very synaptic architecture thought to underlie psychotic disorders, with implications for early intervention strategies.
Using [18F]SynVesT-1, a radiotracer that binds to the synaptic vesicle glycoprotein SV2A, researchers imaged 78 participants — 25 with first-episode psychosis (FEP), 32 at clinical high risk (CHR), and 21 healthy controls — to quantify synaptic density across targeted brain regions. Acute stress, measured by the Hassles and Uplifts Scale, was negatively associated with SV2A binding across the entire cohort (F=12.0, p<0.001), independent of diagnostic group. Chronic stress, assessed via the Trier Inventory, showed a more nuanced pattern: it was inversely linked to synaptic density in healthy controls only, not in clinical groups. Notably, in the FEP group, lower depressive symptom burden — not higher — correlated with reduced synaptic density, a counterintuitive finding warranting replication.
This work sits at an important intersection of stress biology and synaptic neuroscience. Animal models have consistently shown that glucocorticoid-mediated stress responses prune dendritic spines and reduce synaptic density in prefrontal and hippocampal regions, and this study extends that signal into living humans across a psychosis-risk continuum. The SV2A PET approach is relatively new but increasingly validated, offering greater specificity than older synaptic markers. Key limitations include the modest sample size — particularly the 21-person healthy control group — which limits the power to detect subtle group interactions. The cross-sectional design cannot establish whether stress causes synaptic loss or whether individuals with lower synaptic density experience heightened stress reactivity. The absence of a chronic stress effect in clinical groups may reflect a floor effect or stress-response blunting already present in illness. Incremental but methodologically rigorous, this study strengthens the case for stress as a biologically embedded, measurable risk factor in the prodromal phase of psychosis.
